In 2005, Panteli et al. measured the serum levels of IL1α, IL1β, IL2, IL6, soluble IL2 receptor alpha (sIL2-Ra), and Thrombopoietin (TPO) in 25 primary myelofibrosis (PMF), 40 Essential Thrombocytemia (ET), and 8 PV in comparison with a group of 27 healthy subjects and a subgroup of 10 chronic myeloid leukemia (CML) patients [6]. The gene discussed is IL1A; the disease is acquired polycythemia vera.